F2G Ltd.
Executive Summary
F2G Ltd.-the name is an acronym for "Function to Gene"-aims to create new antifungals by disabling genes that are essential to the survival of the fungus. The company is first focusing on aspergillosis, caused by airborne Aspergillus fumigatus, a particularly deadly fungal infection for which current treatments are inadequate.